AMARIN CORP PLC -ADR (AMRN) Stock Analyst Ratings
NASDAQ:AMRN - Nasdaq - US0231112063 - ADR - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to AMRN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.02. This target is 71.72% above the current price.
AMRN was analyzed by 8 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about AMRN.
In the previous month the buy percentage consensus was at a similar level.
AMRN was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-18 | Cantor Fitzgerald | Reiterate | Overweight |
| 2023-11-20 | JP Morgan | Reiterate | Underweight |
| 2023-10-25 | Jefferies | Downgrade | Buy -> Hold |
| 2023-07-20 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-07-19 | Northland Capital Markets | Maintains | Market Perform -> Market Perform |
| 2023-01-06 | Jefferies | Upgrade | Hold -> Buy |
| 2022-10-19 | SVB Leerink | Maintains | Market Perform |
| 2022-05-24 | Goldman Sachs | Maintains | Sell |
| 2022-05-06 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-05-05 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-05-05 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-02-16 | SVB Leerink | Maintains | Outperform |
| 2022-01-31 | SVB Leerink | Maintains | Outperform |
| 2021-09-09 | SVB Leerink | Initiate | Outperform |
| 2021-05-12 | Goldman Sachs | Downgrade | Neutral -> Sell |